Leadheal Hospital
Leadheal Hospital
Republic of Korea, Seoul
Stem cell therapy for arthritis in the Republic of Korea typically costs from Price on request to Price on request . The final price depends on the specific joint, the cell source, and the clinic location in Seoul or Busan. Patients save around _price_percent_discount_% by travelling to South Korea from Australia, where this procedure costs _price_compare_AU_average_ on average. Standard medical packages often include consultations, diagnostic imaging, and laboratory processing.
Bookimed Expert Insight: South Korea offers a high degree of specialisation in regenerative orthopaedics. Nanoori Hospital in Seoul is certified by KOIHA, meaning its quality systems meet international safety standards. With over 80 clinic options, Australians can access experts like Dr. Seong Hyun Kim, who has 30+ years of experience. Large centres like Leadheal Hospital treat over 44,000 patients annually, suggesting high proficiency in managing complex arthritis cases.
No hidden fees – just official clinic prices. Pay at the clinic for Stem cell therapy for arthritis upon arrival and use a flexible instalment plan if needed.
Bookimed is committed to your safety. We only work with medical institutions that maintain high international standards in Stem cell therapy for arthritis and have the necessary licenses to serve international patients worldwide.
Bookimed offers free expert assistance. A personal medical coordinator supports you before, during, and after your treatment, solving any issues. You're never alone on your Stem cell therapy for arthritis journey.
Professor Kwangyeal Lee is a leading specialist in joint reconstruction and regenerative treatments at Nanoori Hospital. He brings high-level expertise from his time as Section Chief of the Joint Centre at Sun Hospital.
Professor Seongcheol Moon serves as the Chairman of the Department of Orthopaedic Surgery at Nanoori Hospital. He is a leading expert in joint restoration and sports medicine with a focus on biological treatments.
Stem cell therapy for arthritis in the Republic of Korea achieves significant pain relief and improved function. This occurs in approximately 70–75% of patients. Specialised treatments like Cartistem have treated over 30,000 patients by June 2024. Success is driven by high-precision imaging and regenerative protocols at accredited Seoul hospitals.
Bookimed Expert Insight: While many countries offer autologous stem cells, South Korea leads in allogeneic treatments like Cartistem. Data shows Nanoori Hospital serves 58,000+ patients annually. Their specialists, such as Dr Seongcheol Moon, maintain memberships in the American Academy of Orthopaedic Surgeons. These memberships ensure international standards of care.
Patient Consensus: Patients travelling to the Republic of Korea suggest requesting official clinical trial data directly from hospitals. Reliable clinics avoid 90%+ success claims and instead provide peer-reviewed evidence regarding joint regeneration outcomes.
Stem cell procedures for arthritis in South Korea are safe. They are highly regulated under the Advanced Regenerative Bio Law. The country approved the first stem cell therapy for knee osteoarthritis in 2012. Government-designated facilities such as Nanoori Hospital must adhere to strict quality standards.
Bookimed Expert Insight: South Korea is unique because it permits on-site cell culturing at specialised clinics. Many countries only allow basic cell processing. Korean clinics like Nanoori Hospital, however, can expand cell populations. This typically leads to higher concentrations of therapeutic cells for joint injections.
Patient Consensus: Patients in the Republic of Korea often seek clinics with published clinical trial data. It is common practice to consult an Australian rheumatologist before travelling. This helps make sure the therapy fits long-term care plans.
Specialists in the Republic of Korea primarily treat knee osteoarthritis with stem cells using the government-approved Cartistem protocol. Clinics also address degenerative joint disease and shoulder or elbow injuries. Expert surgeons like Dr Kwangyeal Lee at Nanoori Hospital have published research. Their work covers stem cell applications for rheumatoid arthritis.
Bookimed Expert Insight: Clinical volume at centres like Nanoori Hospital exceeds 58,000 patients annually. This massive scale allows doctors to specialise by joint rather than just procedure type. This expertise is why surgeons here often have multiple memberships in specific knee and shoulder societies.
Patient Consensus: Patients suggest asking for Ministry of Food and Drug Safety approval on specific products before booking. Most find the process straightforward at designated spine and joint specialty hospitals in Seoul.
Stem cell therapy packages in South Korea typically include specialist consultations and diagnostic imaging like MRIs. They also include the administration of treatments approved by the Ministry of Health and Welfare. Patients often receive Cartistem, a cord blood-derived product. It is usually combined with arthroscopic surgery and microfracture for effective cartilage repair.
Bookimed Expert Insight: While simple injections offer temporary relief, Korea's most successful outcomes come from surgical implantation with scaffolds. Dr Kwangyeal Lee at Nanoori Hospital often uses these protocols. They help 30 to 60 million stem cells stay at the injury site.
Patient Consensus: Patients recommend asking specifically for Cartistem surgical procedures rather than simple injections. They note that a hydrogel scaffold provides better long-term regrowth results in the Republic of Korea.